Disease details

Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01712373 (ClinicalTrials.gov)	December 2010	19/10/2012	Ginseng in Treatment of Fatigue in Multiple Sclerosis	Study of Ginseng in Treatment of Fatigue in Multiple Sclerosis	Fatigue	Drug: Ginseng;Drug: Placebo	Isfahan University of Medical Sciences	NULL	Completed	18 Years	50 Years	Both	60	Phase 2	Iran, Islamic Republic of
2	NCT00754832 (ClinicalTrials.gov)	September 2005	16/9/2008	American Ginseng Treatment for Multiple Sclerosis Related Fatigue	A Double-blinded, Placebo-controlled Crossover Pilot Study of American Ginseng Treatment for Multiple Sclerosis Related Fatigue	Multiple Sclerosis	Drug: American ginseng extract HT-1001;Drug: placebo	Oregon Health and Science University	National Multiple Sclerosis Society	Completed	18 Years	70 Years	All	56	Phase 2	United States